Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
Pitting of malaria parasites in microfluidic devices mimicking spleen interendothelial slits.
Impact of pre-existing drug resistance on risk of virological failure in South Africa.
Adherence to a Supplemented Mediterranean Diet Drives Changes in the Gut Microbiota of HIV-1-Infected Individuals.
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses.
Characterization of RAN Translation and Antisense Transcription in Primary Cell Cultures of Patients with Myotonic Dystrophy Type 1.
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.
JAK-STAT Pathway: A Novel Target to Tackle Viral Infections.
Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test.